Literature DB >> 24602189

Wearable cardioverter-defibrillator in a patient with left ventricular noncompaction/hypertrabeculation, coronary artery disease, and polyneuropathy.

Claudia Stöllberger1, Josef Finsterer.   

Abstract

A 55-year-old Caucasian male with coronary heart disease was admitted because of dyspnea for 4 weeks. Echocardiography showed a dilated left ventricle with an ejection fraction of 34% and apical left ventricular hypertrabeculation/noncompaction with an apical thrombus. Neurologic examination revealed positional tremor and generally reduced tendon reflexes. During 8 weeks, his condition improved under pharmacotherapy. The patient was skeptical about implantable cardioverter-defibrillator (ICD) and expected further improvement from pharmacotherapy. Thus, he received a wearable cardioverter-defibrillator (WCD). We conclude that a WCD might be useful in noncompaction patients in whom improvement of systolic dysfunction is expected or who are skeptical about ICDs.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiomyopathy; heart failure; implantable cardioverter-defibrillator; sudden cardiac death

Mesh:

Year:  2014        PMID: 24602189      PMCID: PMC6931510          DOI: 10.1111/anec.12155

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  7 in total

1.  Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders.

Authors:  Claudia Stöllberger; Josef Finsterer; Gerhard Blazek
Journal:  Am J Cardiol       Date:  2002-10-15       Impact factor: 2.778

2.  [Incidence of coronary artery disease and outcome of patients with left ventricular noncompaction].

Authors:  Xiao-jin Gao; Lian-ming Kang; Jian Zhang; Yong Jiang; Shi-hua Zhao; Min-jie Lu; Huai-bing Cheng; Xiao-liang Luo; Wen Jiang; Rong Lü; Jie Zhu; Yue-jin Yang
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2011-08

3.  Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis.

Authors:  E N Oechslin; C H Attenhofer Jost; J R Rojas; P A Kaufmann; R Jenni
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

4.  Cardiac devices and neuromuscular disorders in left ventricular noncompaction.

Authors:  Claudia Stöllberger; Hans Keller; Gerhard Blazek; Katharina Bichler; Christian Wegner; Josef Finsterer
Journal:  Int J Cardiol       Date:  2011-02-21       Impact factor: 4.164

5.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney
Journal:  Circulation       Date:  2012-12-19       Impact factor: 29.690

6.  Indications and outcome of implantable cardioverter-defibrillators for primary and secondary prophylaxis in patients with noncompaction cardiomyopathy.

Authors:  Kadir Caliskan; Tamas Szili-Torok; Dominic A M J Theuns; Attila Kardos; Marcel L Geleijnse; Aggie H M M Balk; Ron T van Domburg; Luc Jordaens; Maarten L Simoons
Journal:  J Cardiovasc Electrophysiol       Date:  2011-02-18

7.  Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.

Authors:  Andrew E Epstein; William T Abraham; Nicole R Bianco; Karl B Kern; Michael Mirro; Sunil V Rao; Edward K Rhee; Scott D Solomon; Steven J Szymkiewicz
Journal:  J Am Coll Cardiol       Date:  2013-07-31       Impact factor: 24.094

  7 in total
  1 in total

Review 1.  The Wearable Cardioverter/Defibrillator - Toy Or Tool?

Authors:  David Duncker; Christian Veltmann
Journal:  J Atr Fibrillation       Date:  2016-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.